MANAGEMENT OF OUTPATIENT WITH BRONCHOPULM ONARY DYSPLASIA

Bronchopulmonary dysplasia remains a significant clinical problem asso ciated with the success on survival of neonatal intensive care and has become the common est cause of respiratory insufficiency in infants. The severity of the disease is highly variable from asymptomatic chron ic lung disease to patients needing home care with continuous oxygenot herapy and artificial ventilation. Management must try to insure not o nly appropriate growth and neurodevelopment but also satisfactory well being of the patients. Current medications (aerosoltherapy, diuretics , steroids), rules for oxygenotherapy, follow-up and expected evolutio n are discussed according to the severity of the disease.